BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wadei HM, Gonwa TA, Leoni JC, Shah SZ, Aslam N, Speicher LL. COVID-19 infection in solid organ transplant recipients after SARS-CoV-2 vaccination. Am J Transplant 2021. [PMID: 33890410 DOI: 10.1111/ajt.16618] [Cited by in Crossref: 47] [Cited by in F6Publishing: 35] [Article Influence: 47.0] [Reference Citation Analysis]
Number Citing Articles
1 Schimpf J, Sprenger-mähr H, Davidovic T, Lhotta K, Zitt E. Humoral Response in SARS-CoV-2 Convalescent Compared to Vaccinated Kidney Transplant Patients. Transpl Int 2022;35:10060. [DOI: 10.3389/ti.2021.10060] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Pardieck IN, van der Sluis TC, van der Gracht ETI, Veerkamp DMB, Behr FM, van Duikeren S, Beyrend G, Rip J, Nadafi R, Beyranvand Nejad E, Mülling N, Brasem DJ, Camps MGM, Myeni SK, Bredenbeek PJ, Kikkert M, Kim Y, Cicin-Sain L, Abdelaal T, van Gisbergen KPJM, Franken KLMC, Drijfhout JW, Melief CJM, Zondag GCM, Ossendorp F, Arens R. A third vaccination with a single T cell epitope confers protection in a murine model of SARS-CoV-2 infection. Nat Commun 2022;13:3966. [PMID: 35803932 DOI: 10.1038/s41467-022-31721-6] [Reference Citation Analysis]
3 Aslam S, Danziger-Isakov L, Mehra MR. COVID-19 vaccination immune paresis in heart and lung transplantation. J Heart Lung Transplant 2021;40:763-6. [PMID: 34144891 DOI: 10.1016/j.healun.2021.04.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Russo G, Lai Q, Poli L, Perrone MP, Gaeta A, Rossi M, Mastroianni CM, Garofalo M, Pretagostini R. SARS-COV-2 vaccination with BNT162B2 in renal transplant patients: Risk factors for impaired response and immunological implications. Clin Transplant 2021;:e14495. [PMID: 34569101 DOI: 10.1111/ctr.14495] [Reference Citation Analysis]
5 Manuel O. COVID-19 vaccination in solid-organ transplant recipients: generating new data as fast as possible, but taking clinical decisions as slow as necessary. Clin Microbiol Infect 2021;27:1070-1. [PMID: 34153456 DOI: 10.1016/j.cmi.2021.06.018] [Reference Citation Analysis]
6 Filippidis P, Vionnet J, Manuel O, Mombelli M. Prevention of viral infections in solid organ transplant recipients in the era of COVID-19: a narrative review. Expert Rev Anti Infect Ther 2021;:1-18. [PMID: 34854329 DOI: 10.1080/14787210.2022.2013808] [Reference Citation Analysis]
7 Meshram HS, Kute VB, Shah N, Chauhan S, Navadiya VV, Patel AH, Patel HV, Engineer D, Banerjee S, Rizvi J, Mishra VV. COVID-19 in Kidney Transplant Recipients Vaccinated With Oxford-AstraZeneca COVID-19 Vaccine (Covishield): A Single-center Experience From India. Transplantation 2021;105:e100-3. [PMID: 34049359 DOI: 10.1097/TP.0000000000003835] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
8 Yamada M, Matsumoto E, Thomas CP, Carlson JR, Klutts JS, Kumar B, Streit JA, Swee ML. Case Report: Severe COVID-19 in a Kidney Transplant Recipient Without Humoral Response to SARS-CoV-2 mRNA Vaccine Series. Transplant Direct 2021;7:e743. [PMID: 34386580 DOI: 10.1097/TXD.0000000000001193] [Reference Citation Analysis]
9 Peled Y, Ram E, Lavee J, Segev A, Matezki S, Wieder-Finesod A, Halperin R, Mandelboim M, Indenbaum V, Levy I, Sternik L, Raanani E, Afek A, Kreiss Y, Lustig Y, Rahav G. Third dose of the BNT162b2 vaccine in heart transplant recipients: Immunogenicity and clinical experience. J Heart Lung Transplant 2021:S1053-2498(21)02481-5. [PMID: 34565682 DOI: 10.1016/j.healun.2021.08.010] [Cited by in Crossref: 32] [Cited by in F6Publishing: 18] [Article Influence: 32.0] [Reference Citation Analysis]
10 Antolí A, Rocamora-blanch G, Framil M, Mas-bosch V, Navarro S, Bermudez C, Martinez-yelamos S, Dopico E, Calatayud L, Garcia-muñoz N, Hernández-benítez LH, Riera-mestre A, Bas J, Masuet-aumatell C, Rigo-bonnin R, Morandeira F, Solanich X. Evaluation of Humoral and Cellular Immune Responses to the SARS-CoV-2 Vaccine in Patients With Common Variable Immunodeficiency Phenotype and Patient Receiving B-Cell Depletion Therapy. Front Immunol 2022;13:895209. [DOI: 10.3389/fimmu.2022.895209] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Dulek DE, Ardura MI, Green M, Michaels MG, Chaudhuri A, Vasquez L, Danziger-Isakov L, Posfay-Barbe KM, McCulloch MI, L'Huillier AG, Benden C. Update on COVID-19 vaccination in pediatric solid organ transplant recipients. Pediatr Transplant 2022;:e14235. [PMID: 35060251 DOI: 10.1111/petr.14235] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Crespo M, Barrilado-Jackson A, Padilla E, Eguía J, Echeverria-Esnal D, Cao H, Faura A, Folgueiras M, Solà-Porta E, Pascual S, Barbosa F, Hurtado S, Ribera L, Río-No L, Pérez-Sáez MJ, Redondo-Pachón D, Pascual J; Mariscovid Research Group. Negative immune responses to two-dose mRNA COVID-19 vaccines in renal allograft recipients assessed with simple antibody and interferon gamma release assay cellular monitoring. Am J Transplant 2021. [PMID: 34551187 DOI: 10.1111/ajt.16854] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 11.0] [Reference Citation Analysis]
13 Cuadrado A, Del Barrio M, Fortea JI, Amigo L, San Segundo D, Rodriguez-Cundin MP, Rebollo MH, Fernandez-Santiago R, Castillo F, Achalandabaso M, Echeverri J, Anderson EJ, Rodríguez-Sanjuan JC, López-Hoyos M, Crespo J, Fábrega E. Antibody response to the messenger RNA-1273 vaccine (Moderna) in liver transplant recipients. Hepatol Commun 2022. [PMID: 35344281 DOI: 10.1002/hep4.1937] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Hogan JI, Kotton CN. A Call for Caution in the Immunocompromised: Coronavirus Disease 2019 Associated With Mortality in a Vaccinated Lung Transplant Recipient. Open Forum Infect Dis 2021;8:ofab557. [PMID: 34988243 DOI: 10.1093/ofid/ofab557] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Heldman MR, Kates OS, Fisher CE, Limaye AP. Immunosuppression in solid organ transplant recipients with Covid-19: More data, but still complicated. Transpl Infect Dis 2021;23:e13650. [PMID: 34325492 DOI: 10.1111/tid.13650] [Reference Citation Analysis]
16 Marion O, Del Bello A, Abravanel F, Faguer S, Esposito L, Laure Hebral A, Bellière J, Izopet J, Kamar N. Predictive Factors for Humoral Response After 2-dose SARS-CoV-2 Vaccine in Solid Organ Transplant Patients. Transplant Direct 2022;8:e1248. [PMID: 34966837 DOI: 10.1097/TXD.0000000000001248] [Reference Citation Analysis]
17 Deng X, Evdokimova M, O'Brien A, Rowe CL, Clark NM, Harrington A, Reid GE, Uprichard SL, Baker SC. Breakthrough Infections with Multiple Lineages of SARS-CoV-2 Variants Reveals Continued Risk of Severe Disease in Immunosuppressed Patients. Viruses 2021;13:1743. [PMID: 34578324 DOI: 10.3390/v13091743] [Reference Citation Analysis]
18 Massa F, Cremoni M, Gérard A, Grabsi H, Rogier L, Blois M, Couzin C, Hassen NB, Rouleau M, Barbosa S, Martinuzzi E, Fayada J, Bernard G, Favre G, Hofman P, Esnault VLM, Czerkinsky C, Seitz-Polski B, Glaichenhaus N, Sicard A. Safety and cross-variant immunogenicity of a three-dose COVID-19 mRNA vaccine regimen in kidney transplant recipients. EBioMedicine 2021;73:103679. [PMID: 34763205 DOI: 10.1016/j.ebiom.2021.103679] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 D'Offizi G, Agrati C, Visco-Comandini U, Castilletti C, Puro V, Piccolo P, Montalbano M, Meschi S, Tartaglia E, Sorace C, Leone S, Lapa D, Grassi G, Goletti D, Ippolito G, Vaia F, Ettorre GM, Lionetti R. Coordinated cellular and humoral immune responses after two-dose SARS-CoV2 mRNA vaccination in liver transplant recipients. Liver Int 2021. [PMID: 34719107 DOI: 10.1111/liv.15089] [Reference Citation Analysis]
20 Peled Y, Afek A, Nemet I, Rahav G, Raanani E, Patel JK, Mandelboim M. Fourth BNT162b2 Vaccination Neutralization of Omicron Infection after Heart Transplantation. The Journal of Heart and Lung Transplantation 2022. [DOI: 10.1016/j.healun.2022.04.014] [Reference Citation Analysis]
21 Iancovici L, Khateeb D, Harel O, Peri R, Slobodin G, Hazan Y, Melamed D, Kessel A, Bar-On Y. Rheumatoid arthritis patients treated with Janus kinase inhibitors show reduced humoral immune responses following BNT162b2 vaccination. Rheumatology (Oxford) 2021:keab879. [PMID: 34849628 DOI: 10.1093/rheumatology/keab879] [Reference Citation Analysis]
22 Carr EJ, Kronbichler A, Graham-Brown M, Abra G, Argyropoulos C, Harper L, Lerma EV, Suri RS, Topf J, Willicombe M, Hiremath S. Review of Early Immune Response to SARS-CoV-2 Vaccination Among Patients With CKD. Kidney Int Rep 2021;6:2292-304. [PMID: 34250319 DOI: 10.1016/j.ekir.2021.06.027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
23 Nimmo A, Gardiner D, Ushiro-lumb I, Ravanan R, Forsythe JLR. The Global Impact of COVID-19 on Solid Organ Transplantation: Two Years Into a Pandemic. Transplantation 2022;Publish Ahead of Print. [DOI: 10.1097/tp.0000000000004151] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
24 Hod T, Ben-David A, Olmer L, Scott N, Ghinea R, Mor E, Levy I, Indenbaum V, Lustig Y, Grossman E, Rahav G. BNT162b2 Third Booster Dose Significantly Increases the Humoral Response Assessed by Both RBD IgG and Neutralizing Antibodies in Renal Transplant Recipients. Transpl Int 2022;35:10239. [PMID: 35387393 DOI: 10.3389/ti.2022.10239] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Kittleson MM, Chambers DC, Cypel M, Potena L. Covid-19 in recipients of heart and lung transplantation: Learning from experience. J Heart Lung Transplant 2021;40:948-50. [PMID: 34246563 DOI: 10.1016/j.healun.2021.05.021] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Majcherek M, Matkowska-Kocjan A, Szymczak D, Karasek M, Szeremet A, Kiraga A, Milanowska A, Kuznik E, Kujawa K, Wrobel T, Szenborn L, Czyz A. Two Doses of BNT162b2 mRNA Vaccine in Patients after Hematopoietic Stem Cell Transplantation: Humoral Response and Serological Conversion Predictors. Cancers (Basel) 2022;14:325. [PMID: 35053487 DOI: 10.3390/cancers14020325] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
27 Mazuecos A, Villanego F, Zarraga S, López V, Oppenheimer F, Llinàs-Mallol L, Hernández AM, Rivas A, Ruiz-Fuentes MC, Toapanta NG, Jiménez C, Cabello S, Beneyto I, Aladrén MJ, Rodríguez-Benot A, Canal C, Molina M, Pérez-Flores I, Saura IM, Gavela E, Franco A, Lorenzo I, Galeano C, Tabernero G, Pérez-Tamajón L, Martín-Moreno PL, Fernández-Girón F, Siverio O, Labrador PJ, De Arriba G, Simal F, Cruzado L, Moina I, Alcalde G, Sánchez-Álvarez E, Pascual J, Crespo M; Spanish Society of Nephrology COVID-19 Group. Breakthrough Infections Following mRNA SARS-CoV-2 Vaccination in Kidney Transplant Recipients. Transplantation 2022. [PMID: 35384924 DOI: 10.1097/TP.0000000000004119] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
28 Ben-Dov IZ, Oster Y, Tzukert K, Alster T, Bader R, Israeli R, Asayag H, Aharon M, Burstein I, Pri-Chen H, Imam A, Abel R, Mor-Yosef Levi I, Khalaileh A, Oiknine-Djian E, Bloch A, Wolf DG, Dranitzki Elhalel M. Impact of tozinameran (BNT162b2) mRNA vaccine on kidney transplant and chronic dialysis patients: 3-5 months follow-up. J Nephrol 2022. [PMID: 34988942 DOI: 10.1007/s40620-021-01210-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
29 Ponsford MJ, Ward TJC, Stoneham SM, Dallimore CM, Sham D, Osman K, Barry SM, Jolles S, Humphreys IR, Farewell D. A Systematic Review and Meta-Analysis of Inpatient Mortality Associated With Nosocomial and Community COVID-19 Exposes the Vulnerability of Immunosuppressed Adults. Front Immunol 2021;12:744696. [PMID: 34691049 DOI: 10.3389/fimmu.2021.744696] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Schrezenmeier E, Rincon-Arevalo H, Stefanski AL, Potekhin A, Staub-Hohenbleicher H, Choi M, Bachmann F, Pross V, Hammett C, Schrezenmeier H, Ludwig C, Jahrsdörfer B, Lino A, Eckardt KU, Kotsch K, Döerner T, Budde K, Sattler A, Halleck F. B and T Cell Responses after a Third Dose of SARS-CoV-2 Vaccine in Kidney Transplant Recipients. J Am Soc Nephrol 2021:ASN. [PMID: 34667083 DOI: 10.1681/ASN.2021070966] [Reference Citation Analysis]
31 Giannella M, Pierrotti LC, Helanterä I, Manuel O. SARS-CoV-2 vaccination in solid-organ transplant recipients: What the clinician needs to know. Transpl Int 2021;34:1776-88. [PMID: 34450686 DOI: 10.1111/tri.14029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Yi SG, Moore LW, Eagar T, Graviss EA, Nguyen DT, Ibrahim H, Huang HJ, Hobeika M, McMillan R, Saharia A, Mobley C, Podder H, Drews A, Ghobrial RM, Gaber AO, Knight RJ. Risk Factors Associated With an Impaired Antibody Response in Kidney Transplant Recipients Following 2 Doses of the SARS-CoV-2 mRNA Vaccine. Transplant Direct 2022;8:e1257. [PMID: 34912946 DOI: 10.1097/TXD.0000000000001257] [Reference Citation Analysis]
33 Lawrence A, Mahan LD, Mohanka MR, Bollineni S, Kaza V, La Hoz RM, Zhang S, Kershaw CD, Terada LS, Torres F, Banga A. Predictors and outcomes of respiratory failure among lung transplant patients with COVID-19. Clin Transplant 2021;:e14540. [PMID: 34792221 DOI: 10.1111/ctr.14540] [Reference Citation Analysis]
34 Grupper A, Katchman H. SARS-CoV-2 Vaccines: Safety and Immunogenicity in Solid Organ Transplant Recipients and Strategies for Improving Vaccine Responses. Curr Transpl Rep. [DOI: 10.1007/s40472-022-00359-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
35 Kumari K, Kumar A, Bahadur I, Singh P. Investigate the interaction of testosterone/progesterone with ionic liquids on varying the anion to combat COVID-19: Density functional theory calculations and molecular docking approach. J Phys Org Chem 2021;:e4273. [PMID: 34511718 DOI: 10.1002/poc.4273] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
36 Vinson AJ, Anzalone AJ, Sun J, Dai R, Agarwal G, Lee SB, French E, Olex A, Ison MG, Mannon RB; N3C consortium. The risk and consequences of breakthrough SARS-CoV-2 infection in solid organ transplant recipients relative to non-immunosuppressed controls. Am J Transplant 2022. [PMID: 35674237 DOI: 10.1111/ajt.17117] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Cassaniti I, Bergami F, Arena F, Sammartino JC, Ferrari A, Zavaglio F, Curti I, Percivalle E, Meloni F, Pandolfi L, Pellegrini C, Turco A, Seminari E, Pattonieri EF, Gregorini M, Rampino T, Sarasini A, Lilleri D, Baldanti F. Immune Response to BNT162b2 in Solid Organ Transplant Recipients: Negative Impact of Mycophenolate and High Responsiveness of SARS-CoV-2 Recovered Subjects against Delta Variant. Microorganisms 2021;9:2622. [PMID: 34946223 DOI: 10.3390/microorganisms9122622] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
38 Chukwu CA, Mahmood K, Elmakki S, Gorton J, Kalra PA, Poulikakos D, Middleton R. Evaluating the antibody response to SARS-COV-2 vaccination amongst kidney transplant recipients at a single nephrology centre. PLoS One 2022;17:e0265130. [PMID: 35271655 DOI: 10.1371/journal.pone.0265130] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]